Antech Study Shows KeyScreen™ Detects Twice as Many Parasite-Positive Samples as Two Standard Screening Methods Combined

Antech Study Demonstrates KeyScreen GI Parasite PCR Detects Twice as Many Parasite-Positive Samples as Traditional Testing Methods Antech™, a global leader in veterinary diagnostics, has announced the publication of a…

Read MoreAntech Study Shows KeyScreen™ Detects Twice as Many Parasite-Positive Samples as Two Standard Screening Methods Combined

Obsidian Therapeutics to Present Updated Amsoki-cel Clinical Data in Advanced Melanoma at SITC 2026

Obsidian Therapeutics Reports Promising Amsoki-Cel Results in ICI-Resistant Advanced Melanoma, With 67% Response Rate Obsidian Therapeutics, a clinical-stage biopharmaceutical company developing engineered tumor-infiltrating lymphocyte (TIL) cell therapies through its proprietary…

Read MoreObsidian Therapeutics to Present Updated Amsoki-cel Clinical Data in Advanced Melanoma at SITC 2026

Onchilles Pharma Presents First Clinical Data for N17350 as a Potential Personalized Cancer Vaccine at SITC 2026

Onchilles Pharma Presents Preliminary Clinical Findings for N17350, an Investigational Intratumoral Cancer Therapy, at SITC 2026 Onchilles Pharma, a clinical-stage biotechnology company developing next-generation cancer therapies targeting the ELANE pathway,…

Read MoreOnchilles Pharma Presents First Clinical Data for N17350 as a Potential Personalized Cancer Vaccine at SITC 2026